Peripheral axotomy influences the in vivo release of cholecystokinin in the spinal cord dorsal horn-possible involvement of cholecystokinin-B receptors

Brain Research

Volumn 790, Issue 1-2, 1998, Pages 141-150

  Gustafsson, Henrik ^a   Lucas, Guilherme De Araújo ^b   Schött, Eva ^a   Stiller, Carl Olav ^a   Alster, Pawel ^b   Wiesenfeld Hallin, Zsuzsanna ^b   Brodin, Ernst ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Axotomy; C1988; Cholecystokinin; Microdialysis; Rat; Spinal cord

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IMMUNOREACTIVITY; MICRODIALYSIS; NERVE FIBER TRANSECTION; NEUROMODULATION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RECEPTOR UPREGULATION; SCIATIC NERVE; SENSORY NERVE; SPINAL CORD DORSAL HORN;

ANIMALS; ANTI-ANXIETY AGENTS; AXOTOMY; CHOLECYSTOKININ; INDOLES; MALE; MEGLUMINE; MICRODIALYSIS; POTASSIUM; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; SCIATIC NERVE; SPINAL CORD;

EID: 0344734181     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00060-2     Document Type: Article

References (66)

1. L.R. Allard, M.C. Beinfeld, Vasoactive intestinal polypeptide (VIP) inhibits potassium-induced release of cholecystokinin (CCK) from rat caudato-putamen but not from cerebral cortex, Neuropeptides 8 (1986) 287-293.
2. L.R. Allard, M.C. Beinfeld, Phorbol esters stimulate the potassium-induced release of cholecystokinin from slices of cerebral cortex, caudato-putamen, and hippocampus incubated in vitro, Biochem. Res. Commun. 153 (1988) 372-376.
3. N.S. Baber, C.T. Dourish, D.R. Hill, The role of CCK caerulein, and CCK antagonists in nociception, Pain 39 (1989) 307-328.
4. B.S. Barbaz, W.L. Autry, F.G. Ambrose, N.R. Hall, J.M. Liebman, Antinociceptive profile of sulfated CCK-8: comparison with CCK-4, unsulfated CCK-8 and other neuropeptides, Neuropharmacology 25 (1986) 823-829.
5. A.J. Bean, M.J. During, R.H. Roth, Stimulation-induced release of coexistent transmitters in prefrontal cortex: an in vivo microdialysis study of dopamine and neurotensin release, J. Neurochem. 53 (1989) 655-657.
6. M.C. Beinfeld, Cholecystokinin (CCK) release from rat brain slices in vitro is enhanced by agents which elevate intracellular cAMP, Reg. Pept. 67 (1996) 75-77.
7. J.J. Benoliel, S. Bourgoin, A. Mauborgne, M. Pohl, J.C. Legrand, M. Hamon, F. Cesselin, GABA, acting at both GABA-A and GABA-B receptors, inhibits the release of cholecystokinin-like material from the rat spinal cord in vitro, Brain Res. 590 (1992) 255-262.
8. E. Brodin, N. Lindefors, U. Ungerstedt, Potassium-evoked in vivo release of substance P in rat caudate nucleus measured using a new technique of brain dialysis and an improved substance P-radioimmunoassay, Acta Physiol. Scand. Suppl. 515 (1983) 17-20.
9. E. Brodin, B. Linderoth, B. Gazelius, U. Ungerstedt, In vivo release of substance P in cat dorsal horn studied with microdialysis, Neurosci. Lett. 76 (1987) 357-362.
10. J.S. Brog, M.C. Beinfeld, Cholecystokinin release from the rat caudate-putamen, cortex and hippocampus is increased by activation of the D1 dopamine receptor, J. Pharmacol. Exp. Ther. 260 (1992) 343-348.
11. S.P. Butcher, A. Varro, J.S. Kelly, G.J. Dockray, In vivo studies on the enhancement of cholecystokinin release in the rat striatum by dopamine depletion, Brain Res. 505 (1989) 119-122.
12. J.M. Castro-Lopes, I. Tavares, A. Coimbra, GABA decreases in the spinal cord dorsal horn after peripheral neurectomy, Brain Res. 620 (1993) 287-291.
13. F. Cesselin, Opioid and anti-opioid peptides, Fundam. Clin. Pharmacol. 9 (1995) 409-433.
14. M. Conrath-Verrier, M. Dietl, G. Tramu, Cholecystokinin-like immunoreactivity in the dorsal horn of the spinal cord of the rat: a light and electron microscopic study, Neuroscience 13 (1984) 871-885.
15. S. De Mesquita, M.C. Beinfeld, J.N. Crawley, Microdialysis as an approach to quantitate the release of neuropeptides, Prog. Neuro-Psychopharmacol. Biol. Psychiatry 14 (1991) S5-S15.
16. A.H. Dickenson, Neurophysiology of poorly responsive pain, Cancer Surv. 21 (1994) 5-16.
17. A.H. Dickenson, Where and how do opioids act?, in: G.F. Gebhart, T.S. Jensen (Eds.), Proceedings of the 7th World Congress on Pain, Vol. 2, IASP Press, Seattle, 1994, pp. 525-552.
18. G.J. Dockray, R.A. Gregory, J.I. Harris, J.B. Hutchison, M.J. Runswick, Two cholecystokinin-like octapeptides from brain: isolation, structure, immunochemical characterization and biological activity, J. Physiol. 280 (1978) 16P-17P.
19. A. El-Bohy, C.C. LaMotte, Deafferentation-induced changes in neuropeptides of the adult rat dorsal horn following pronase injection of the sciatic nerve, J. Comp. Neurol. 336 (1993) 545-554.
20. P.L. Faris, B. Komisaruk, L.R. Watkins, D.J. Mayer, Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia, Science 219 (1983) 310-312.
21. E.R. Forster, G.J. Dockray, The putative CCK-B receptor antagonist CI-988 stimulates pancreatic secretion in the anesthetized rat, Regul. Pept. 35 (1991) 237.
22. J.S. Han, X.Z. Ding, S.G. Fan, Is cholecystokinin octapeptide (CCK-8) a candidate for endogenous anti-opioid substrates?, Neuropeptides 5 (1985) 399-402.
23. R.G. Hill, J. Hughes, K.M. Pittaway, Antinociceptive action of cholecystokinin octapeptide (CCK-8) and related peptides in rats and mice: effects of naloxone and peptidase inhibitors, Neuropharmacology 26 (1987) 289-300.
24. T. Hökfelt, X. Zhang, Z. Wiesenfeld-Hallin, Messenger plasticity in primary sensory neurons following axotomy and its functional implications, TINS 17 (1994) 22-30.
25. T. Hökfelt, X. Zhang, Z.-Q. Xu, R.-R. Ji, T. Shi, J. Corness, N. Kerekes, M. Landry, M. Rydh-Rinder, C. Broberger, Z. Wiesenfeld-Hallin, T. Bartfai, R. Eide, G. Ju, Transition of pain from acute to chronic: cellular and synaptic mechanisms, in: T.S. Jensen, K. Turner, Z. Wiesenfeld-Hallin (Eds.), Proceedings of the 8th World Congress on Pain, Vol. 9, IASP Press, Seattle, 1997, in press.
26. H.-Z. Hu, Z.-V. Li, J.-Q. Si, Evidence for the existence of substance P autoreceptors in the membrane of rat dorsal root ganglion, Neuroscience 77 (1997) 535-541.
27. S. Itoh, G. Katsuura, Y. Maeda, Caerulein and cholecystokinin suppress β-endorphin-induced analgesia in the rat, Eur. J. Pharmacol. 80 (1982) 421-425.
28. G. Ju, T. Hökfelt, J.A. Fischer, P. Frey, J.F. Rehfeld, G.J. Dockray, Does cholecystokinin-like immunoreactivity in rat primary sensory neurons represent calcitonin gene-related peptide?, Neurosci. Lett. 68 (1986) 305-310.
29. I. Jurna, G. Zetler, Antinociceptive effect of centrally administered caerulein and cholecystokinin octapeptide, Eur. J. Pharmacol. 73 (1981) 323-331.
30. Y. Katz, A. Weizman, C.G. Pick, G.W. Pasternak, L. Liu, O. Fonia, M. Gavish, Interactions between laudanosine, GABA, and opioid subtype receptors: implication for laudanosine seizure activity, Brain Res. 646 (1994) 235-241.
31. I. Loren, J. Alumets, R. Hakanson, F. Sundler, Distribution of gastrin and CCK-like peptides in rat brain: an immunocytochemical study, Histochemistry 59 (1979) 249-257.
32. G.A. Lucas, X.-J. Xu, Z. Wiesenfeld-Hallin, The role of cholecystokinin in the mediation of spinal excitability in normal rats and after peripheral nerve injury, Soc. Neurosci. Abstr. 23 (1997) 455.
33. R. Maciewicz, B.S. Phipps, J. Grenier, C.E. Poletti, Edinger-Westphal nucleus: cholecystokinin immunocytochemistry and projections to spinal cord and trigeminal nucleus in the cat, Brain Res. 299 (1984) 139-145.
34. N.T. Maidment, D.R. Brumbaugh, V.D. Rudolph, E. Erdelyi, C.J. Evans, Microdialysis of extracellular endogenous opioid peptides from rat brain in vivo, Neuroscience 33 (1989) 549-557.
35. N.T. Maidment, B.J. Siddall, V.R. Rudolph, E. Erdelyi, C.J. Evans, Dual determination of the extracellular cholecystokinin and neurotensin fragments in the rat forebrain: microdialysis combined with a sequential multiple antigen radioimmunoassay, Neuroscience 45 (1991) 81-93.
36. J. Mao, D.D. Price, D.J. Mayer, R.L. Hayes, Pain-related increases in spinal cord membrane-bound protein kinase C following peripheral nerve injury, Brain Res. 588 (1992) 144-149.
37. J.J. Meana, M. Herrera-Marschitz, E. Brodin, T. Hökfelt, U. Ungerstedt, Simultaneous determination of cholecystokinin, dopamine, glutamate and aspartate in cortex and striatum of the rat using in vivo microdialysis, Amino Acids 1 (1991) 365-373.
38. I. Nevo, C. Becker, M. Hamon, J.J. Benoliel, Stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat: prevention by diazepam but not ondansetron, J. Neurochem. 66 (1996) 2041-2049.
39. U. Nielsch, P. Keen, Reciprocal regulation of tachykinin- and vasoactive intestinal peptide-gene expression in rat sensory neurons following cut and crush injury, Brain Res. 481 (1989) 25-30.
40. Y. Nishizuka, Studies and perspectives of proteins kinase C, Science 233 (1986) 305-312.
41. K.M. Pittaway, R.E. Rodriguez, J. Hughes, R.G. Hill, CCK-8 analgesia and hyperalgesia after intrathecal administration in the rat: comparison with CCK-related peptides, Neuropeptides 10 (1987) 87-108.
42. M. Pohl, E. Collin, J.J. Benoliel, S. Bourgoin, F. Cesselin, M. Hamon, Cholecystokinin (CCK)-like material and CCK-mRNA levels in the rat brain and spinal cord after acute or repeated morphine treatment, Neuropeptides 21 (1992) 193-200.
43. A. Ravovska, Cholecystokinin-GABA interactions in rat striatum, Neuropeptides 29 (1995) 257-262.
44. J.F. Rehfeld, Immunochemical studies on cholecystokinin: I. Development of sequence-specific radioimmunoassays for porcine triacontatriapeptide cholecystokinin, J. Biol. Chem. 253 (1978) 4016-4021.
45. A. Rosén, J. Franck, E. Brodin, Effects of acute systemic treatment with the 5-HT-uptake blocker alaproclate on tissue levels and release of substance P in rat periaqueductal grey, Neuropeptides 28 (1995) 317-324.
46. S.N. Schiffmann, J.J. Vanderhaeghen, Distribution of cells containing mRNA encoding cholecystokinin in the rat central nervous system, J. Comp. Neurol. 304 (1991) 219-233.
47. S.A. Shehab, M.E. Atkinson, Vasoactive intestinal polypeptide increases in areas of the dorsal horn of the spinal cord from which other neuropeptides are depleted following peripheral axotomy, Exp. Brain Res. 62 (1986) 422-430.
48. L. Skirboll, T. Hökfelt, G. Dockray, J. Gehfeld, M. Brownstein, A.C. Cuello, Evidence of periaqueductal cholecystokinin-substance P neurons projecting to the spinal cord, J. Neurosci. 3 (1983) 1151-1157.
49. K. Starke, M. Gothert, H. Kilbinger, Modulation of neurotransmitter release by presynaptic autoreceptor, Physiol. Rev. 69 (1989) 864-989.
50. C.-O. Stiller, J. Bergquist, O. Beck, R. Ekman, E. Brodin, Local administration of morphine decreases the extracellular level of GABA in the periaqueductal gray matter of freely moving rats, Neurosci. Lett. 209 (1996) 165-168.
51. M. Takita, T. Tsuruta, Y. Oh-hashi, T. Kato, In vivo release of cholecystokinin-like immunoreactivity in rat frontal cortex under freely moving conditions, Neurosci. Lett. 100 (1989) 249-253.
52. J.J. Vanderhaeghen, C. Deschepper, F. Lotstra, G. Vierendeels, J. Schoenen, Immunohistochemical evidence for cholecystokinin-like peptides in neuronal cell bodies of the rat spinal cord, Cell Tissue Res. 223 (1982) 463-467.
53. V.M.K. Verge, Z. Wiesenfeld-Hallin, T. Hökfelt, Cholecystokinin in mammalian primary sensory neurons and spinal cord: in situ hybridization studies in rat and monkey, Eur. J. Neurosci. 5 (1993) 240-250.
54. L.R. Watkins, I.B. Kinscheck, D.J. Mayer, Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide, Science 224 (1984) 395-396.
55. Z. Wiesenfeld-Hallin, R. Duranti, Intrathecal cholecystokinin interacts with morphine but not substance P in modulating the nociceptive flexion reflex in the rat, Peptides 8 (1987) 153-158.
56. P.R. Wilson, T.L. Yaksh, Baclofen is antinociceptive in the spinal intrathecal space of animals, Eur. J. Pharmacol. 51 (1978) 323-330.
57. X.-J. Xu, M.J.C. Puke, V.M.K. Verge, Z. Wiesenfeld-Hallin, J. Hughes, T. Hökfelt, Upregulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat, Neurosci. Lett. 152 (1993) 129-132.
58. X.-J. Xu, J.X. Hao, A. Seiger, J. Hughes, T. Hökfelt, Z. Wiesenfeld-Hallin, Chronic pain-related behaviors in spinally injured rats: evidence for functional alterations of the endogenous cholecystokinin and opioid system, Pain 56 (1994) 271-277.
59. X.-J. Xu, T. Hökfelt, J. Hughes, Z. Wiesenfeld-Hallin, The CCK-B antagonist CI 988 enhances the reflex depressive effect of morphine in axotomized rat, NeuroReport 5 (1994) 718-720.
60. Yaksh, E.O. Abay, V.L.W. Go, Studies on the location and release of cholecystokinin and vasoactive intestinal peptide in rat and cat spinal cord, Brain Res. 242 (1982) 279-290.
61. T.L. Yaksh, T. Furui, I.S. Kanawati, V.L.W. Go, Release of cholecystokinin from rat cerebral cortex in vivo: role of GABA and glutamate receptor systems, Brain Res. 406 (1987) 207-214.
62. L. Yang, N.D. Thomas, C.J. Heike, Characterization of substance P release from intermediate area of rat thoracic spinal cord, Synapse 23 (1996) 265-273.
63. Z.B. You, M. Herrera-Marschitz, E. Brodin, J.J. Meana, P. Morini, T. Hökfelt, R. Silveira, M. Goiny, U. Ungerstedt, On the origin of striatal cholecystokinin release: studies with in vivo microdialysis, J. Neurochem. 62 (1994) 76-85.
64. G. Zetler, Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK), Neuropharmacology 19 (1980) 415-422.
65. X. Zhang, A. Dagerlind, R.P. Eide, M.-N. Castel, C. Broberger, Z. Wiesenfeld-Hallin, T. Hökfelt, Marked increase in cholecystokinin B receptor messenger RNA levels in rat dorsal root ganglia after peripheral axotomy, Neuroscience 57 (1993) 233-337.
66. D. Zouaoui, J.J. Benoliel, M. Conrath, F. Cesselin, Cholecystokinin-like immunoreactivity in the dorsal horn of the rat spinal cord: an attempt to analyze contradictory results between immunocytochemistry and radioimmunoassay, Neuropeptides 17 (1990) 177-185.